Rosalia Busà

12PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersMolecular targetsBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Image and video coding
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 10, 2026
Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study.

Rosalia Busà, Giovanna Panarello, Alessia Gallo

|Dec 30, 2025
Glypican-3-Specific CAR NK Cells Co-Secreting IL-15 and IFN-α Have Increased Anti-Tumor Function Versus Hepatocellular Carcinoma In Vitro.

Rosalia Busà, Gioacchin Iannolo, Bruno Douradinha

|Jun 16, 2025
Engineering a Human-Sized Common Bile Duct Prototype with Regenerative Potential: In Vitro Evaluation of Mechanics, Function, Degradation, and Immune Modulation.

Mattia Pasqua, Marianna Barbuto, Matteo Calligaris

|Mar 29, 2023
Role of Mesenchymal Stem/Stromal Cells in Modulating Ischemia/Reperfusion Injury: Current State of the Art and Future Perspectives.

Vitale Miceli, Matteo Bulati, Alessia Gallo

|Feb 24, 2023
Proof-of-Concept Analysis of B Cell Receptor Repertoire in COVID-19 Patients Undergoing ECMO by Single-Cell V(D)J and Gene Expression Sequencing.

Alessia Gallo, Nicola Cuscino, Claudia Carcione

|Dec 11, 2022
Long-Term Effectiveness of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine on B Cell Compartment: Efficient Recall of SARS-CoV-2-Specific Memory B Cells.

Rosalia Busà, Monica Miele, Maria Concetta Sorrentino

Pageof 2

Frequent Collaborators

8 joint publications

Pier Giulio Conaldi

7 joint publications

Matteo Bulati

5 joint publications

Gioacchin Iannolo

4 joint publications

Giovanna Russelli